Am. J. Respir. Crit. Care Med., Volume 158, Number 6, December 1998, 1730-1738

Active Detection of Chronic Obstructive Pulmonary Disease and Asthma in the General Population
Results and Economic Consequences of the DIMCA Program

GUIDO van den BOOM, CONSTANT P. van SCHAYCK, MAUREEN P. M. H. RUTTEN- van MÖLKEN, PRASANNA R. S. TIRIMANNA, JOOST J. den OTTER, PIERRE M. van GRUNSVEN, MAJA J. BUITENDIJK, CEES L. A. van HERWAARDEN, and CHRIS van WEEL

Departments of Pulmonology and of General Practice and Social Medicine, University of Nijmegen, Nijmegen; Department of Health Organization, Policy and Economics, University of Maastricht, Maastricht; and Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands

The aim of this prospective study was to detect subjects in the general population with objective signs of chronic obstructive pulmonary disease (COPD) or asthma at an early stage. This was done by means of a two-stage protocol involving screening and a subsequent 2-yr monitoring of all subjects with positive results of screening. The study was done in 10 general practices located in the eastern part of the Netherlands. A random sample was taken from the general population aged 25 to 70 yr. All known COPD and asthma patients were excluded. A total of 1,749 subjects met the inclusion criteria: 1,155 subjects (66%) agreed to participate in the screening stage of the study. A total of 604 subjects (52.3%) showed symptoms or objective signs of COPD or asthma during the screening and were considered "positive." Of those with positive screening results, 384 subjects (64%) agreed to participate in the second, 2-yr monitoring stage of the study. The costs involved in detection were calculated for three different scenarios, as follows: (1) The detection of subjects with persistently decreased lung function or an increased level of bronchial hyperresponsiveness (BHR) during 6 mo of monitoring; (2) Scenario 1 plus the detection of subjects with a rapid decline in lung function with signs of BHR during 12 mo of monitoring; (3) Scenario 2 plus the detection of subjects with a moderate increase in the decline in lung function or signs of BHR during 24 mo of monitoring. The costs of lung function assessments, organization, transportation, and patient time were included. The costs were converted to United States dollars on the basis of purchasing power (1 United States dollar = 2.08 Netherlands guilders). During the second stage, 252 subjects were detected with objective signs of COPD or asthma at an early stage. Smoking status as a screening criterion was neither sensitive nor specific. Because there was no evidence of biased recruitment or selection during the program, the proportions of subjects found to have objective signs of COPD or asthma at an early stage could be extrapolated to the general population. Of the general population, 7.7% showed persistently reduced lung function or increased BHR. Another 12.5 % of the general population showed a rapid decline in lung function (> 80 ml/yr) in combination with signs of BHR, and a further 19.4% of the general population showed mild objective signs of COPD or asthma. The average costs per detected case varied from US$953 (Scenario 1) to US$469 (Scenario 3). In conclusion, detection of COPD or asthma at an early stage by means of a two-stage protocol was feasible at relatively little expense in comparison with other mass screening programs. Persistently decreased lung function or a rapid decline in lung function (Scenario 2) was observed in approximately 20% of the general adult population.

This article has been cited by other articles:

				J A Walters, E C Hansen, D P Johns, E L Blizzard, E H Walters, and R Wood-Baker A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD Thorax, May 1, 2008; 63(5): 408 - 414. [Abstract] [Full Text] [PDF]

				M Albers, T Schermer, Y Heijdra, J Molema, R Akkermans, and C van Weel Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease Thorax, March 1, 2008; 63(3): 201 - 207. [Abstract] [Full Text] [PDF]

				M. Lusuardi, F. De Benedetto, P. Paggiaro, C. M. Sanguinetti, G. Brazzola, P. Ferri, and C. F. Donner A Randomized Controlled Trial on Office Spirometry in Asthma and COPD in Standard General Practice : Data From Spirometry in Asthma and COPD: a Comparative Evaluation Italian Study,{dagger}. Chest, April 1, 2006; 129(4): 844 - 852. [Abstract] [Full Text] [PDF]

				S. Zanconato, G. Meneghelli, R. Braga, F. Zacchello, E. Baraldi, and on behalf of the Working Group Office Spirometry in Primary Care Pediatrics: A Pilot Study Pediatrics, December 1, 2005; 116(6): e792 - e797. [Abstract] [Full Text] [PDF]

				M. Albers, T. Schermer, and C. van Weel Airflow Limitation as a Screening Tool Chest, October 1, 2005; 128(4): 1898 - 1900. [Full Text] [PDF]

				D. Wilson, R. Adams, S. Appleton, R. Ruffin, and on behalf of the North West Adelaide (Cohort) Stud Difficulties Identifying and Targeting COPD and Population-Attributable Risk of Smoking for COPD: A Population Study Chest, October 1, 2005; 128(4): 2035 - 2042. [Abstract] [Full Text] [PDF]

				L. Iversen, P. C. Hannaford, D. B. Price, and D. J. Godden Is Living in a Rural Area Good for Your Respiratory Health?: Results From a Cross-sectional Study in Scotland Chest, October 1, 2005; 128(4): 2059 - 2067. [Abstract] [Full Text] [PDF]

				R. E. Dales, K. L. Vandemheen, J. Clinch, and S. D. Aaron Spirometry in the Primary Care Setting: Influence on Clinical Diagnosis and Management of Airflow Obstruction Chest, October 1, 2005; 128(4): 2443 - 2447. [Abstract] [Full Text] [PDF]

				L. Huiart, P. Ernst, and S. Suissa Cardiovascular Morbidity and Mortality in COPD Chest, October 1, 2005; 128(4): 2640 - 2646. [Abstract] [Full Text] [PDF]

				P. K. Myint, R. N. Luben, P. G. Surtees, N. W. J. Wainwright, A. A. Welch, S. A. Bingham, N. J. Wareham, N. E. Day, and K-T. Khaw Respiratory function and self-reported functional health: EPIC-Norfolk population study Eur. Respir. J., September 1, 2005; 26(3): 494 - 502. [Abstract] [Full Text] [PDF]

				A. Bohadana, F. Nilsson, and Y. Martinet Detecting Airflow Obstruction in Smoking Cessation Trials: A Rationale for Routine Spirometry Chest, September 1, 2005; 128(3): 1252 - 1257. [Abstract] [Full Text] [PDF]

				M. Albers, T. Schermer, G. van den Boom, R. Akkermans, C. van Schayck, C. van Herwaarden, and C. van Weel Efficacy of Inhaled Steroids in Undiagnosed Subjects at High Risk for COPD: Results of the Detection, Intervention, and Monitoring of COPD and Asthma Program Chest, December 1, 2004; 126(6): 1815 - 1824. [Abstract] [Full Text] [PDF]

				G. Viegi, G. Matteelli, A. Angino, A. Scognamiglio, S. Baldacci, J. B. Soriano, and L. Carrozzi The Proportional Venn Diagram of Obstructive Lung Disease in the Italian General Population Chest, October 1, 2004; 126(4): 1093 - 1101. [Abstract] [Full Text] [PDF]

				J. Buffels, J. Degryse, J. Heyrman, and M. Decramer Office Spirometry Significantly Improves Early Detection of COPD in General Practice: The DIDASCO Study Chest, April 1, 2004; 125(4): 1394 - 1399. [Abstract] [Full Text] [PDF]

				V. WinklerPrins, L. van den Nieuwenhof, H. van den Hoogen, H. Bor, and C. van Weel The Natural History of Asthma in a Primary Care Cohort Ann. Fam. Med, March 1, 2004; 2(2): 110 - 115. [Abstract] [Full Text] [PDF]

				R J Adams, D H Wilson, S Appleton, A Taylor, E Dal Grande, C R Chittleborough, and R E Ruffin Underdiagnosed asthma in South Australia Thorax, October 1, 2003; 58(10): 846 - 850. [Abstract] [Full Text] [PDF]

				T R Schermer, J E Jacobs, N H Chavannes, J Hartman, H T Folgering, B J Bottema, and C van Weel Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) Thorax, October 1, 2003; 58(10): 861 - 866. [Abstract] [Full Text] [PDF]

				The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1S - 44s. [Full Text] [PDF]

				S.T. Weiss, D.L. DeMeo, and D.S. Postma COPD: problems in diagnosis and measurement Eur. Respir. J., June 1, 2003; 21(41_suppl): 4S - 12s. [Abstract] [Full Text] [PDF]

				B. Lundback, A. Gulsvik, M. Albers, P. Bakke, E. Ronmark, G. van den Boom, J. Brogger, L-G. Larsson, I. Welle, C. van Weel, et al. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Eur. Respir. J., May 1, 2003; 21(40_suppl): 3S - 9s. [Abstract] [Full Text] [PDF]

				C.P. van Schayck and N.H. Chavannes Detection of asthma and chronic obstructive pulmonary disease in primary care Eur. Respir. J., January 1, 2003; 21(39_suppl): 16S - 22s. [Abstract] [Full Text] [PDF]

				C P van Schayck, J M C Loozen, E Wagena, R P Akkermans, and G J Wesseling Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study BMJ, June 8, 2002; 324(7350): 1370 - 1370. [Abstract] [Full Text] [PDF]

				D. B. COULTAS, D. MAPEL, R. GAGNON, and E. LYDICK The Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States Adults Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 372 - 377. [Abstract] [Full Text] [PDF]

				L Dow, L Fowler, L Phelps, K Waters, D Coggon, A L Kinmonth, and S T Holgate Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK Thorax, June 1, 2001; 56(6): 472 - 476. [Abstract] [Full Text]

				M. Decramer, P.N.R. Dekhuijzen, T. Troosters, C. van Herwaarden, M. Rutten-van Molken, C.P.O. van Schayck, D. Olivieri, I. Lankhorst, and A. Ardia The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design Eur. Respir. J., March 1, 2001; 17(3): 329 - 336. [Abstract] [Full Text] [PDF]

				B. Thoonen and C. van Weel Self management in asthma care BMJ, December 16, 2000; 321(7275): 1482 - 1483. [Full Text]

				J. B Soriano, W. C Maier, P. Egger, G. Visick, B. Thakrar, J. Sykes, and N. B Pride Recent trends in physician diagnosed COPD in women and men in the UK Thorax, September 1, 2000; 55(9): 789 - 794. [Abstract] [Full Text]

				C P van Schayck, F M M A van der Heijden, G van den Boom, P R S Tirimanna, and C L A van Herwaarden Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project Thorax, July 1, 2000; 55(7): 562 - 565. [Abstract] [Full Text]

				P. M. A. Calverley COPD : Early Detection and Intervention Chest, May 1, 2000; 117(5_suppl_2): 365S - 371S. [Abstract] [Full Text] [PDF]

				A. CROCKETT Screening older patients for obstructive airways disease Thorax, June 1, 1999; 54(6): 472 - 473. [Full Text]